MedPath

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000823
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To determine the relative antiviral activity and safety of zidovudine ( AZT ) and didanosine ( ddI ) alone and in combination, as well as in various sequences of administration.

The relative efficacy of the approved antiretrovirals in early HIV-1 disease is unclear; thus, a study is needed to evaluate the ability of these various nucleoside analogs to limit pathogenicity.

Detailed Description

The relative efficacy of the approved antiretrovirals in early HIV-1 disease is unclear; thus, a study is needed to evaluate the ability of these various nucleoside analogs to limit pathogenicity.

Patients undergo observation for 2 weeks, then are randomized to one of six treatment arms to receive ddI alone or in sequence or combination with AZT for 16-32 weeks, followed by 4 weeks of post-treatment evaluation. The regimens are: ddI alone for 32 weeks; AZT for 16 weeks followed by ddI for 16 weeks; AZT for 16 weeks followed by AZT/ddI combination for 16 weeks; ddI for 16 weeks followed by AZT for 16 weeks; AZT/ddI combination for 32 weeks; and placebo for 32 weeks.

PER AMENDMENT 6/18/96: NOTE: Patients enrolled under version 3 of the study will terminate treatment at week 16 and have a 4 week follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

Univ of Alabama at Birmingham

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

San Francisco Gen Hosp

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Univ of Colorado Health Sciences Ctr

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

Univ of Miami School of Medicine

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Northwestern Univ Med School

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Cook County Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Rush Presbyterian - Saint Luke's Med Ctr

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Louis A Weiss Memorial Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Illinois Masonic Med Ctr

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Indiana Univ Hosp

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Scroll for more (12 remaining)
Univ of Alabama at Birmingham
πŸ‡ΊπŸ‡ΈBirmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.